[1] 徐云升,郝飞,钟白玉,等.人乳头瘤病毒16 E7抗原细胞毒性T细胞预测表位合成肽的纯化与鉴定.中华皮肤科杂志,2003,36:284. [2] Fujie T, Tahara K, Tanaka F, et al. A MAGE-1-encoded HLAA24-binding synthetic peptide induces specific anti-tumor cytotoxic T lymphocytes. Int J Cancer, 1999, 80:169-172. [3] de Jong A, O'Neill T, Khan AY, et al. Enhancement of human papillomavirus (HPV) type 16 E6 and E7-specific T-cell immunity in healthy volunteers through vaccination with TA-CIN, an HPV16 L2E7E6 fusion protein vaccine. Vaccine, 2002, 20:3456-3464. [4] Oiso M, Eura M, Katsura F, et al. A newly identified MAGE-3-derived epitope recognized by HLA-A24-restricted cytotoxic T lymphocytes. Int J Cancer, 1999, 81:387-394. [5] 徐云升,郝飞HPV16型E7抗原表位的研究进展.中华皮肤科杂志,2003,36:300-302. [6] Yewdell JW,Hill AB.Viral interference with antigen presentation.Nat Immunol,2002,3:1019-1025. [7] 唐旭,赵玉铭,董小平,等.尖锐湿疣患者外周血中HPV DNA的检测.中华皮肤科杂志,2003,36:258-260. |